Key result
Cilostazol treatment prevented the enhanced contractile responses to endothelin-1 and impaired acetylcholine-induced relaxation observed in the middle cerebral artery of ApoE-deficient mice.
p-value: p=<0.01
Cilostazol prevents cerebrovascular endothelial dysfunction in a hypercholesterolemic mouse model, likely by increasing eNOS phosphorylation and activity.
Supports cilostazol for cerebrovascular endothelial protection in hypercholesterolemic models; leaves open human translation.
Hypercholesterolemia is associated with decreased nitric oxide (NO) bioavailability and endothelial dysfunction, a phenomenon thought to have a major role in the altered cerebral blood flow evident in stroke. Therefore, strategies that increase endothelial NO production have potential utility. Vascular reactivity of the middle cerebral artery (MCA) from C57BL/6J wild-type (WT) mice, apolipoprotein-E knockout (ApoE(-/-)) mice, and mice treated with the phosphodiesterase inhibitor cilostazol (100 mg/kg) was analyzed using the tension myograph. Contractile responses to endothelin-1 were significantly enhanced in MCA from ApoE(-/-) mice compared with WT mice (P<0.01), an effect absent in cilostazol-treated ApoE(-/-) mice. Acetylcholine-induced relaxation (which is entirely NO-dependent) was significantly impaired in MCA of ApoE(-/-) mice compared with WT mice (P<0.05), again an effect prevented by cilostazol treatment. Endothelial NOS phosphorylation at Ser(1179) was decreased in the aorta of ApoE(-/-) mice compared with WT mice (P<0.05), an effect normalized by cilostazol. Taken together, our data suggest that the endothelial dysfunction observed in MCA associated with hypercholesterolemia is prevented by cilostazol, an effect likely due to the increase in eNOS phosphorylation and, therefore, activity.
No takes yet. Share an insight, caveat, or question.
Yamashiro et al. (2010) studied Hypercholesterolemia and cerebrovascular dysfunction. Cilostazol vs. Untreated ApoE(-/-) mice and WT mice was evaluated on Contractile responses to endothelin-1 and acetylcholine-induced relaxation in the middle cerebral artery (p=<0.01). Cilostazol treatment prevented the enhanced contractile responses to endothelin-1 and impaired acetylcholine-induced relaxation observed in the middle cerebral artery of ApoE-deficient mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: